Skip to main content
Livermore
Livermore
ZHEN

Vaughan & Co Securities, Inc.

SEC CIK
0000805870
Latest filing
Aug 3, 2026

GSK holding history

GSK plc in every 13F filed by Vaughan & Co Securities, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
16,231
Value
$850.8K
% of portfolio
0.4%
Quarters held
21
Since Q1 2021
Holdings of GSK by Vaughan & Co Securities, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,231$850.8K0.4%−642−3.8%ReducedHolders
Q1 202616,873$931.2K0.5%−784−4.4%ReducedHolders
Q4 202517,657$865.9K0.4%−1,361−7.2%ReducedHolders
Q3 202519,018$820.8K0.4%+379+2.0%AddedHolders
Q2 202518,639$715.7K0.4%−69−0.4%ReducedHolders
Q1 202518,708$724.7K0.4%+4,805+34.6%AddedHolders
Q4 202413,903$470.2K0.3%−59−0.4%ReducedHolders
Q3 202413,962$570.8K0.3%−55−0.4%ReducedHolders
Q2 202414,017$539.7K0.3%−616−4.2%ReducedHolders
Q1 202414,633$627.3K0.4%−1,827−11.1%ReducedHolders
Q4 202316,460$610.0K0.4%−529−3.1%ReducedHolders
Q3 202316,989$615.9K0.5%−207−1.2%ReducedHolders
Q2 202317,196$612.9K0.4%−90−0.5%ReducedHolders
Q1 202317,286$615.0K0.5%−6,773−28.2%ReducedHolders
Q4 202224,059$845.4K0.7%+24,059NewHolders
Q3 20220$00.0%−16,667−100.0%Sold outHolders
Q2 202216,667$726.0K0.6%−200−1.2%ReducedHolders
Q1 202216,867$735.0K0.5%−130−0.8%ReducedHolders
Q4 202116,997$750.0K0.5%+518+3.1%AddedHolders
Q3 202116,479$630.0K0.5%00.0%UnchangedHolders
Q2 202116,479$656.0K0.5%00.0%UnchangedHolders
Q1 202116,479$588.0K0.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.